Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus and Metformin in Advanced Solid Tumors
NCT02145559Phase 1Completed
- Sponsor
- University of Chicago
- Start
- Apr 2014
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of metformin in solid tumor (advanced stage) (2 arms), sponsored by University of Chicago. Primary endpoint: Pharmacodynamic Biomarker p70S6K at 28 days. Started Apr 2014; status: completed.
02
Drugs
metformin
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT02145559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02145559.